KINERET Swedish Orphan Biovitrum Pty Ltd

KINERET (anakinra) is proposed to treat adults with Adult-Onset Still’s Disease (AOSD), a rare inflammatory condition. KINERET is proposed for people who have active symptoms affecting the whole body and whose condition has not improved despite using non-biological disease-modifying antirheumatic drugs (DMARDs). DMARDs normally reduce inflammation and slow the immune system’s attack on the body.